Olga Brawman-Mintzer to Drug Therapy, Combination
This is a "connection" page, showing publications Olga Brawman-Mintzer has written about Drug Therapy, Combination.
Connection Strength
0.171
-
Adjunctive risperidone in generalized anxiety disorder: a double-blind, placebo-controlled study. J Clin Psychiatry. 2005 Oct; 66(10):1321-5.
Score: 0.056
-
New trends in the treatment of anxiety disorders. CNS Spectr. 2004 Aug; 9(8 Suppl 7):19-27.
Score: 0.051
-
A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults. J Clin Psychopharmacol. 2018 Aug; 38(4):336-343.
Score: 0.034
-
Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies. J Affect Disord. 2016 Dec; 206:151-160.
Score: 0.029